BT Wearables v. Fossil Group: Five-Patent Smartwatch Dispute Ends in 141 Days
BT Wearables LLC asserted five U.S. patents covering health-monitoring and activity-tracking functionality against Fossil Group’s Gen 5 and Gen 6 smartwatch lines. Filed in the Eastern District of Texas before Judge Rodney Gilstrap, the case closed by joint dismissal with prejudice after just 141 days — a resolution timeline consistent with a confidential settlement.
Five wearable-tech patents, one smartwatch maker, one swift joint exit
On April 10, 2025, BT Wearables LLC filed suit against Fossil Group, Inc. in the U.S. District Court for the Eastern District of Texas (Case No. 2:25-cv-00381), asserting infringement of five patents directed at wearable health-monitoring technology. The accused products included Fossil’s Gen 6, Gen 6 Hybrid, and Gen 5 LTE smartwatches, along with associated apps and hardware — specifically targeting features such as calorie-burn calculation, accelerometer and heart-rate sensing, exercise selection, speech-command execution, mobile phone pairing, and activity identification.
The case closed on August 29, 2025, when both parties filed a Joint Motion to Dismiss with Prejudice under Federal Rule of Civil Procedure 41(a)(2). Judge Rodney Gilstrap granted the motion, ordering the case dismissed with prejudice and directing each side to bear its own costs, expenses, and attorneys’ fees. A dismissal with prejudice extinguishes BT Wearables’ right to re-file the same claims against Fossil Group on these five patents — the dispute is permanently resolved at the district court level.
At 141 days from filing to closure, the resolution is notably swift for a five-patent infringement action in the Eastern District of Texas, where patent cases frequently extend well beyond a year. The joint nature of the motion and the ‘own costs’ fee allocation are consistent with a confidential settlement, though no financial terms have been disclosed in the public record. What drove the rapid resolution — whether claim-scope weaknesses, licensing agreement, or commercial negotiation — remains unknown from publicly available documents.
Filing to Dismissed with Prejudice in 141 days
141 days — well below the E.D. Texas median for patent cases reaching trial
Dismissed with prejudice: what the joint motion means for both parties
Rule 41(a)(2): a court-ordered permanent close
A dismissal with prejudice under Federal Rule of Civil Procedure 41(a)(2) is a final adjudication on the merits for res judicata purposes. Because both parties jointly requested it, the court had no reason to impose conditions. The practical effect: BT Wearables cannot re-file these exact claims against Fossil Group on the same five patents in any U.S. federal court. The legal dispute is closed permanently at the district level.
Permanent bar on re-filingBT Wearables forfeits the right to re-litigate these claims
By agreeing to dismissal with prejudice, BT Wearables surrendered the ability to bring these five patents back against Fossil Group in future litigation. This is a meaningful concession compared to a without-prejudice dismissal, which would preserve optionality. Whether BT Wearables received consideration — a licence fee, royalty stream, or cross-licence — in exchange for this concession is not disclosed in the public record, but the structure is consistent with a negotiated resolution.
No re-filing permittedFossil Group secures certainty over its Gen 5 and Gen 6 lines
For Fossil Group, the with-prejudice dismissal provides finality: BT Wearables’ five asserted patents can no longer be wielded against the Gen 5 LTE, Gen 6, and Gen 6 Hybrid product lines in a new action. Represented by Fish & Richardson LLP, Fossil avoided a full merits battle in a plaintiff-friendly venue. The ‘own costs’ fee allocation suggests neither party claimed a clear litigation win, consistent with a negotiated exit rather than a capitulation.
Freedom from re-assertion on these patentsSmartwatch health-monitoring IP remains an active enforcement frontier
The swift closure does not diminish the underlying patent portfolio’s relevance. BT Wearables’ five patents cover core wearable functions — calorie tracking, heart-rate sensing, activity recognition, voice commands — that span the smartwatch industry broadly. Other wearable OEMs should note that these patents remain in force and potentially assertable against their own products. The E.D. Texas filing confirms this portfolio is being actively monetised.
Portfolio remains live against othersFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | BT Wearables, LLC | Company | Wearable-technology patent assertion entity — holder of US10362940B2 and four related health-monitoring patentsSearch in Eureka ↗ |
| Defendant | Fossil Group, Inc. | Company | Fossil Group, Inc. — global smartwatch and wearable device manufacturer (Gen 5/6 product lines)Search in Eureka ↗ |
| Plaintiff counsel | James Francis McDonough , III | Attorney | Counsel for BT Wearables, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Rozier Hardt McDonough PLLC | Law Firm | Representing BT Wearables, LLCSearch in Eureka ↗ |
| Defendant counsel | Ricardo Joel Bonilla. | Attorney | Counsel for Fossil Group, Inc.Search in Eureka ↗ |
| Defendant law firm | Fish & Richardson LLP | Law Firm | Representing Fossil Group, Inc.Search in Eureka ↗ |
| Presiding judge | Judge Rodney Gilstrap | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The joint motion language — ‘each party is to bear its own costs, expenses, and attorneys’ fees’ — is a standard marker of a negotiated resolution in which neither side claims a litigation victory. The with-prejudice designation goes beyond a routine administrative closure: it operates as a final merits bar, foreclosing BT Wearables from reasserting these five patents against Fossil Group’s accused smartwatch products in any future action. The denial of all other pending relief as moot confirms no injunctive or damages orders were entered, consistent with settlement prior to substantive judicial engagement on the merits.
US10362940B2 and four related patents — wearable health-monitoring systems
The five asserted patents — US10362940B2, US10729336B1, US9204796B2, US11051704B1, and US9775520B2 — form a cohesive portfolio directed at core smartwatch functionality. Application dates span from US13/952607 (filed circa 2013) through to later continuations, suggesting a patent family built over roughly a decade of prosecution. The claims collectively cover calorie-burn calculation and wireless data transmission, accelerometer and heart-rate sensor integration, exercise-mode user inputs, speech-command processing, mobile device pairing, and automated activity identification.
This portfolio’s strategic breadth is notable: rather than protecting a narrow implementation, the patents appear to target functional capabilities now standard across the wearable market — Fitbit, Apple Watch, Samsung Galaxy Watch, and Garmin devices all incorporate subsets of these feature categories. For Fossil Group specifically, the Gen 6 line’s Wear OS platform and health-suite integration made it a natural target. Any wearable OEM shipping devices with heart-rate monitoring, GPS activity tracking, or voice-assistant integration should regard this portfolio as a live enforcement risk requiring assessment.
Should you run an FTO against US10362940B2 and the BT Wearables portfolio?
If your product roadmap includes smartwatches, fitness bands, or health-monitoring wearables with calorie tracking, heart-rate sensing, activity recognition, voice commands, or mobile-device pairing, this five-patent portfolio warrants a formal freedom-to-operate review. The swift settlement with Fossil Group — a major OEM — suggests the claims have sufficient credibility to compel licensing discussions without reaching claim construction.
PatSnap Eureka’s FTO Search Agent can map each independent claim in US10362940B2, US10729336B1, US9204796B2, US11051704B1, and US9775520B2 against your product’s technical architecture, identify prior art that could support IPR petitions, and surface related continuations or divisionals that may extend the family’s reach. Early FTO analysis is substantially cheaper than responding to E.D. Texas infringement complaints.
Run a freedom-to-operate analysis on US10362940B2 to assess your product’s exposure
Run FTO in Eureka →Similar wearable-technology patent cases in E.D. Texas and related courts
Explore comparable NPE-asserted wearable health-monitoring and smartwatch patent cases filed in the Eastern District of Texas and related federal courts.
What this case signals for the wearable technology IP landscape
A five-patent smartwatch enforcement action resolved in 141 days carries clear signals for wearable OEMs and their IP teams.
E.D. Texas remains the venue of choice for wearable-tech patent assertions
BT Wearables’ choice of Judge Gilstrap’s court — consistently among the busiest patent dockets in the U.S. — reflects the continued strategic appeal of E.D. Texas for NPE plaintiffs. Wearable device manufacturers should maintain current FTO analyses and monitor new filings in this district against comparable product categories.
Health-monitoring feature patents carry real settlement leverage
Five patents covering calorie tracking, accelerometer-based activity recognition, heart-rate sensing, and voice commands represent a broad functional net. The rapid resolution suggests Fossil Group calculated that licensing or settlement was more efficient than extended litigation — a calculus other smartwatch and fitness-tracker makers may face from the same portfolio.
BT v Fossil — key questions answered
BT Wearables asserted five U.S. patents: US10362940B2, US10729336B1, US9204796B2, US11051704B1, and US9775520B2. The patents collectively cover wearable health-monitoring functions including calorie-burn calculation, accelerometer and heart-rate sensing, exercise selection, speech-command execution, mobile phone pairing, and activity identification — all targeted at Fossil Gen 5 and Gen 6 smartwatch lines.
A with-prejudice dismissal is a permanent resolution. BT Wearables is barred from re-filing the same infringement claims against Fossil Group based on these five patents in any U.S. federal court. Unlike a without-prejudice dismissal — which preserves the right to refile — this closure is final. The order also denied all other pending relief as moot and directed each party to bear its own costs.
The 141-day resolution is notably short for a five-patent infringement case in the Eastern District of Texas, where patent litigation commonly extends well over a year. The joint nature of the dismissal motion and the mutual ‘own costs’ fee allocation are consistent with a confidential settlement or licensing agreement reached before substantive litigation milestones such as claim construction. No financial terms are disclosed in the public record.
The complaint targeted Fossil Gen 6, Gen 6 Hybrid, and Gen 5 LTE smartwatches, along with associated apps (including the Fossil Smartwatches App) and related hardware and software. Specifically accused features included calorie-burn calculation and remote data transmission, exercise-selection user inputs, accelerometer and heart-rate sensor functionality, speech-command execution, and mobile telephone coupling.
Yes, the five patents remain in force and are potentially assertable against other wearable OEMs. The portfolio’s claims cover foundational smartwatch health features — heart-rate monitoring, activity recognition, calorie tracking, and voice commands — that are broadly deployed across the industry. The Fossil settlement suggests the patents carry licensing leverage. Manufacturers of competing smartwatches and fitness trackers should consider a formal FTO review against this portfolio.
PatSnap Eureka searches patents and litigation data to answer instantly.